Table 2 Extent of exposure of more common pediatric rheumatic diseases during entire fellowship
From: Current pediatric rheumatology fellowship training in the United States: what fellows actually do
Diseases/Syndromes (Column A) | Number of patients with the corresponding disease (Column B) | ||||
|---|---|---|---|---|---|
0–5 patients | 6–10 patients | 11–20 patients | >20 patients | ||
Systemic JIA | Percentage of fellows who saw the patients in each group of column -B with diseases listed in column –A | 16% | 47% | 28% | 9% |
Poly JIA | 4% | 7% | 14% | 75% | |
Oligo JIA | 4% | 0% | 15% | 81% | |
Enthesitis-related JIA | 7% | 16% | 25% | 52% | |
SLE-New case | 30% | 34% | 32% | 4% | |
SLE-existing diagnosis | 11% | 14% | 32% | 43% | |
SLE with nephritis | 21% | 25% | 27% | 27% | |
JDM-new case | 57% | 30% | 4% | 9% | |
JDM-existing diagnosis | 31% | 30% | 25% | 14% | |
Scleroderma | 47% | 29% | 20% | 4% | |
Streptococcal syndromes | 20% | 39% | 37% | 4% | |
Resistant HSP | 54% | 30% | 9% | 7% | |
Kawasaki Disease | 21% | 46% | 19% | 14% | |
Sarcoidosis | 61% | 34% | 5% | 0% | |
Pain syndromes | 2% | 16% | 18% | 64% | |